Galea Life Sciences' BioSource Therapeutics, Inc. Subsidiary Names Edward Martin to its Board of Directors

Published: Feb 13, 2008

MIAMI, Feb. 13, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announces that its wholly-owned subsidiary, BioSource Therapeutics, Inc. (BST), has named Edward Martin to its Board of Directors. BST is the maker of Nutraplete(tm) Therapeutic Drink Mix, the first dietary supplement product designed specifically for people living with HIV/AIDS.

Back to news